Anti-CD19 CAR T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and NHL
Clinical trial NCT03373071 · COMPLETED
Trial details
- NCT number
- NCT03373071
- Sponsor
- Bambino Gesù Hospital and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-23
- Primary completion
- 2021-05-11
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.